- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 491/08 - Bridged systems
Patent holdings for IPC class C07D 491/08
Total number of patents in this class: 596
10-year publication summary
|
62
|
46
|
61
|
40
|
39
|
59
|
48
|
41
|
58
|
11
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
18 |
| F. Hoffmann-La Roche AG | 7958 |
16 |
| Pfizer Inc. | 3322 |
15 |
| Merck Sharp & Dohme LLC | 3689 |
15 |
| Merck Patent GmbH | 5909 |
14 |
| Hoffmann-La Roche Inc. | 3060 |
13 |
| Vertex Pharmaceuticals Incorporated | 1581 |
12 |
| Genentech, Inc. | 3742 |
11 |
| Amgen Inc. | 3779 |
11 |
| Epizyme, Inc. | 383 |
11 |
| Janssen Pharmaceutica N.V. | 3839 |
10 |
| Zevra Therapeutics, Inc. | 85 |
10 |
| Rigel Pharmaceuticals, Inc. | 613 |
9 |
| Boehringer Ingelheim International GmbH | 4629 |
8 |
| H. Lundbeck A/S | 1252 |
7 |
| Skyhawk Therapeutics, Inc. | 93 |
7 |
| Novartis AG | 11238 |
6 |
| Takeda Pharmaceutical Company Limited | 2961 |
6 |
| Astellas Pharma Inc. | 1145 |
6 |
| Bodor Laboratories, Inc. | 59 |
6 |
| Other owners | 385 |